Company intelligence / Profile preview
Regenelead Therapies
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Regenelead Therapies is a China-based biotech with a clinical-stage pipeline covering gene therapy, biologicals, and immunotherapies focused on neurodegeneration, vascular disease, oncology, and ophthalmology. Its programs are in early- to mid-clinical development (Preclinical to Phase 2); key data on safety and preliminary efficacy being generated, but no pivotal or commercial-stage results yet[2][3][1].
- Therapeutic areas
- OncologyNeurologyOphthalmologyCardiovascular
- Modalities
- Biological productsAAV based gene therapyTherapeutic vaccinemRNA vaccineMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Guangdong General Hospital (clinical collaborator on mRNA cancer vaccine/NSCLC)[2]Fudan University (collaborator on pancreatic cancer vaccine study)[2]
Beyond the preview
Go deeper on Regenelead Therapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenelead Therapies.